164 related articles for article (PubMed ID: 18984422)
21. THRIVE score predicts ischemic stroke outcomes and thrombolytic hemorrhage risk in VISTA.
Flint AC; Faigeles BS; Cullen SP; Kamel H; Rao VA; Gupta R; Smith WS; Bath PM; Donnan GA;
Stroke; 2013 Dec; 44(12):3365-9. PubMed ID: 24072004
[TBL] [Abstract][Full Text] [Related]
22. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
23. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
[TBL] [Abstract][Full Text] [Related]
24. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset.
Diedler J; Ahmed N; Sykora M; Uyttenboogaart M; Overgaard K; Luijckx GJ; Soinne L; Ford GA; Lees KR; Wahlgren N; Ringleb P
Stroke; 2010 Feb; 41(2):288-94. PubMed ID: 20056933
[TBL] [Abstract][Full Text] [Related]
25. The presence of a right-to-left shunt is associated with dramatic improvement after thrombolytic therapy in patients with acute ischemic stroke.
Kimura K; Iguchi Y; Shibazaki K; Terasawa Y; Aoki J; Matsumoto N
Stroke; 2009 Jan; 40(1):303-5. PubMed ID: 18845803
[TBL] [Abstract][Full Text] [Related]
26. The impact of intracranial carotid artery calcification on the development of thrombolysis-induced intracerebral hemorrhage.
Lin TC; Chao TH; Shieh Y; Lee TH; Chang YJ; Lee JD; Peng TI; Chang KC; Liou CW; Chang TY; Hung KL; Chang CH
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e455-62. PubMed ID: 23800497
[TBL] [Abstract][Full Text] [Related]
27. Validation assessment of risk scores to predict postthrombolysis intracerebral haemorrhage.
Cucchiara B; Kasner S; Tanne D; Levine S; Demchuk A; Messe S; Sansing L; Lees K; Lyden P;
Int J Stroke; 2011 Apr; 6(2):109-11. PubMed ID: 21371270
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies.
Whiteley WN; Slot KB; Fernandes P; Sandercock P; Wardlaw J
Stroke; 2012 Nov; 43(11):2904-9. PubMed ID: 22996959
[TBL] [Abstract][Full Text] [Related]
29. Blood pressure variability after intravenous thrombolysis in acute stroke does not predict intracerebral hemorrhage but poor outcome.
Kellert L; Sykora M; Gumbinger C; Herrmann O; Ringleb PA
Cerebrovasc Dis; 2012; 33(2):135-40. PubMed ID: 22179586
[TBL] [Abstract][Full Text] [Related]
30. Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke.
Palumbo V; Boulanger JM; Hill MD; Inzitari D; Buchan AM;
Neurology; 2007 Mar; 68(13):1020-4. PubMed ID: 17389306
[TBL] [Abstract][Full Text] [Related]
31. Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.
Uyttenboogaart M; Koch MW; Koopman K; Vroomen PC; De Keyser J; Luijckx GJ
Arch Neurol; 2008 May; 65(5):607-11. PubMed ID: 18332238
[TBL] [Abstract][Full Text] [Related]
32. Subtherapeutic warfarin is not associated with increased hemorrhage rates in ischemic strokes treated with tissue plasminogen activator.
Vergouwen MD; Casaubon LK; Swartz RH; Fang J; Stamplecoski M; Kapral MK; Silver FL;
Stroke; 2011 Apr; 42(4):1041-5. PubMed ID: 21350204
[TBL] [Abstract][Full Text] [Related]
33. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
[TBL] [Abstract][Full Text] [Related]
34. Risk of intracerebral hemorrhage after thrombolysis in patients with asymptomatic hemorrhage on T2*.
Aoki J; Shibazaki K; Saji N; Uemura J; Sakamoto Y; Kimura K
Cerebrovasc Dis; 2014; 38(2):107-16. PubMed ID: 25277866
[TBL] [Abstract][Full Text] [Related]
35. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
[TBL] [Abstract][Full Text] [Related]
36. Safety of intravenous thrombolysis in acute ischemic stroke patients with saccular intracranial aneurysms.
Mittal MK; Seet RC; Zhang Y; Brown RD; Rabinstein AA
J Stroke Cerebrovasc Dis; 2013 Jul; 22(5):639-43. PubMed ID: 22341666
[TBL] [Abstract][Full Text] [Related]
37. Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke.
Millan M; Sobrino T; Castellanos M; Nombela F; Arenillas JF; Riva E; Cristobo I; García MM; Vivancos J; Serena J; Moro MA; Castillo J; Dávalos A
Stroke; 2007 Jan; 38(1):90-5. PubMed ID: 17138950
[TBL] [Abstract][Full Text] [Related]
38. The smoking-thrombolysis paradox and acute ischemic stroke.
Fisher M
Neurology; 2006 Feb; 66(3):458; author reply 458. PubMed ID: 16476964
[No Abstract] [Full Text] [Related]
39. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
[TBL] [Abstract][Full Text] [Related]
40. Intravenous thrombolysis with neuroprotective therapy by edaravone for ischemic stroke patients older than 80 years of age.
Kono S; Deguchi K; Morimoto N; Kurata T; Yamashita T; Ikeda Y; Narai H; Manabe Y; Takao Y; Kawada S; Kashihara K; Takehisa Y; Inoue S; Kiriyama H; Abe K
J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):1175-83. PubMed ID: 23507462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
